Anna Wuolikainen

发表

ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.

P. Andersen, T. Moritz, S. Marklund, 2012, Molecular genetics and metabolism.

Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS

P. Andersen, T. Moritz, S. Marklund, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

P. Andersen, T. Moritz, S. Marklund, 2011, PloS one.

Metabolomics Studies of ALS A multivariate search for clues about a devastating disease.

Anna Wuolikainen, Anna Wuolikainen, 2009 .

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

Henrik Antti, Pär Jonsson, Thomas Moritz, 2016, Molecular bioSystems.

NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects

P. Andersen, L. Forsgren, S. Marklund, 2016, Metabolomics.

Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis.

Johan Lindberg, Johan Trygg, Henrik Antti, 2006, Journal of proteome research.

A 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden

P. Andersen, A. Birve, S. Marklund, 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor

P. Andersen, Jure Acimovic, P. Parini, 2014, PloS one.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study

P. Andersen, M. Benatar, J. Wuu, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

I. Brandslund, P. Andersen, M. Wirenfeldt, 2020, Neurology: Neuroimmunology & Neuroinflammation.

NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects

P. Andersen, L. Forsgren, S. Marklund, 2016, Metabolomics.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at −80 °C

I. Johansson, S. Marklund, H. Lakso, 2019, Clinical Mass Spectrometry.

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

T. Olsson, F. Al Nimer, M. Khademi, 2013, PloS one.

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

K. Blennow, H. Zetterberg, L. Forsgren, 2014, Journal of Parkinson's disease.

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.

P. Andersen, A. Birve, S. Marklund, 2015, Human molecular genetics.

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

J. Glass, J. Connor, M. Cudkowicz, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples

P. Stattin, H. Antti, E. Chorell, 2015, Metabolomics.

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS

P. Andersen, L. Forsgren, T. Moritz, 2019, Journal of Molecular Neuroscience.

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics

K. Blennow, P. Andersen, H. Zetterberg, 2021, Scientific Reports.

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

P. Andersen, L. Forsgren, T. Moritz, 2016, Molecular bioSystems.